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ABSTRACT
International law globally plays a key role in the surveillance and control of communicable 
diseases. Throughout the nineteenth century, international law played a dominant role in 
harmonizing the inconsistent national quarantine regulations of European nation states; 
facilitating the exchange of epidemiological information on infectious diseases; establishing 
international health organizations; and standardization of surveillance. Today, due to changed 
forms of infectious diseases and individuals’ lifestyles as well as individuals’ proximity caused 
by increased air travels, communicable diseases are in an international and cross-border form. 
In this regard, binding regulations and inconsistent rules adopted in international multilateral 
institutions like the World Health Organization, World Trade Organization, Food and Agriculture 
Organization can be of great use in surveillance and control of communicable diseases. With the 
globalization of public health, international law can be used as an essential tool in monitoring 
global health and reducing human vulnerability and mortality.
INTRODUCTION
Since the inception of international law in the Treaty of 
Westphalia in 1648 until the mid-nineteenth century, it was 
widely believed that diseases did not come within the norma-
tive confines of international law; however, the rapid trans-
mission of the cholera outbreak within 1830-1847 in Europe 
facilitated the formation of the first multilateral surveillance 
of communicable diseases (1). The first relationship between 
international law and communicable diseases was formed 
during the mid-nineteenth century and the first international 
conference on health explicitly formed in 1851 in France (2). 
Notwithstanding more than the 150 years of subsequent mul-
tilateral linkage of law and communicable diseases, contem-
porary multilateral/global health governance continues to 
evoke debate in public health discourses (3). This analysis 
focused on the treaty-making powers of the World Health 
Organization (WHO) and those parts of the World Trade 
Organization (WTO) Agreements on Trade-related Aspects 
of Intellectual Property Rights (TRIPS) (4). In short, the in-
ternational law can be defined as the regulator of role and 
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behavior in the case of states included in an international 
system (1,5). In addition, the vital role of the international 
law in the control of infectious diseases is associated with 
the nature of the communicable diseases threat (5).
PUBLIC HEALTH GLOBALIZATION AND 
CHALLENGES OF GOVERNANCE
The term ‘Public Health Globalization’ has emerged in pol-
icy discourses to express the transnational and international 
nature of public health threats (including the spread of infec-
tious diseases and globalization of diseases) (2). Commu-
nicable diseases do not respect the geopolitical boundaries 
of nation states, and state sovereignty is an alien concept 
in the microbial world and all of humanity is vulnerable to 
communicable diseases threats (1,2). The contemporary glo-
balization of the world political economy (as evidenced by 
the large volumes of goods, people, and services that cross 
national borders) has complicated the international law chal-
lenge in the global control of communicable diseases (6). 
Contagious and transmissible diseases have emerged as an 
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important topic in the international law and their ramifica-
tions traverse a range of multilateral regimes including In-
ternational Health Regulations (IHR) of the World Health 
Organization, Agreements of the WTO (TRIPS), Food and 
Agriculture Organization (FAO) and so on. Global and mul-
tilateral governance of communicable diseases implicates 
other sub-categories of international law, including Interna-
tional Human Rights Law, Humanitarian Law and the Laws 
of War, International Environmental law, Law of the Sea, In-
ternational Maritime Law, and Intellectual Property Law and 
Bioethics (7,8). Communicable diseases present enormous 
international challenges that are currently beyond the gov-
ernance capabilities of individual nation states and require 
multilateral and global interventions (8). Historically, it 
seems that international laws can significantly help the states 
solve this problem through making bilateral and multilateral 
conventions that are transnational in nature (2).
NINETEENTH-CENTURY INTERNATIONAL 
SANITARY CONFERENCES
First International Conference on Health was convened in 
1851 in France with the participation of 11 European coun-
tries (9,10). Subsequently, 8 health conventions on trans-
boundary spread of cholera, yellow fever, and plague were 
formed and negotiated across European geographical bor-
ders. In most of these conferences, no legislative proposal 
was approved and no diplomatic efforts were also made in 
this regard (10). In these conferences, epidemiological infor-
mation of diseases was further communicated (3). First con-
ferences on cholera, yellow fever, and plague were held in 
America in 1905 (11). The legacy of the nineteenth-century 
public health diplomacy still inspires the reach and grasp of 
contemporary international law to regulate the globalization 
of emerging and re-emerging communicable diseases within 
the mandates of WHO and other multilateral institutions (4).
INTERNATIONAL LAW SOURCES AND THEIR 
HISTORICAL IMPORTANCE IN CONTROLLING 
COMMUNICABLE DISEASES
International Agreements
According to international lawyers, international agreements 
and customary international law are generally two sources of 
international law (3,4). International agreements are an im-
portant historical source of international law in controlling 
infectious diseases (3). The laws on the control of infectious 
diseases are similar to international economic law and inter-
national environmental law, which are strongly developed 
based on treaties (12). Major International Health Regula-
tions (IHR) show that the international agreements will be 
pursued as an important function in controlling infectious 
diseases (13). The IHR aims to ensure the maximum pro-
tection against the international spread of diseases with 
minimum interference with the world traffic (14). The IHR 
Framework developed by the health conventions contains 
the following objectives (14,15):
1. Notification of the outbreaks of special diseases
2. Restricting the reactions of other countries and being 
informed of the outbreak
3. Being led by an international health organization.
The World Health Organization has failed to meet the 
expectations of the WHO advocates in terms of protecting 
them against infectious diseases (16). Although the WHO is 
carrying out its activities, it is suffering from political and 
financial constraints imposed by the member states (17).
Customary International
Law there are customary international laws which are com-
patible with international laws like getting informed of out-
breaks in other countries and adopting necessary measures to 
prevent the disease in other countries (18).
General Principles of Laws Recognized by Civilized 
Nations
These are not of paramount importance since the public 
health legislation applicable across these countries cannot be 
adopted for their inter-relationships (19).
Judicial Decisions
They are also of no importance because there is no judicial 
decision for infectious diseases in accordance with the inter-
national law (20).
Soft Law
Health regulations can be used as soft laws since they are 
non-binding commitments and the WHO applies their in-
terpretation as recommendation but not binding commit-
ments (20).
WHO, COMMUNICABLE DISEASES AND 
INTERNATIONAL HEALTH REGULATIONS
International Health Regulations were adopted in 1951 by 
the WHO. The IHR is a set of regulations adopted under the 
auspices of the WHO and is one of the first multilateral mon-
itoring mechanisms with a focus on global surveillance of 
infectious diseases (14).
The IHR became legally binding in 1997 for all mem-
ber countries of the WHO except Australia (10). The IHR 
contains a set of regulations on controlling and sharing epi-
demiological information on cross-border spread of cholera, 
plague and yellow fever (18). The basic principle is to ensure 
the maximum protection against the international spread of 
diseases with minimum interference with the world traf-
fic (4). In order to achieve this principle, some obligatory 
regulations were adopted for all member states of the WHO 
to inform the incidence of these three diseases within their 
territory (13). Evaluating the effectiveness of the IHR in 
controlling the global spread of cholera, yellow fever, and 
plague revealed that member states of the WHO have not 
fully observed the provisions (14). One of the major reasons 
is that these countries are afraid of excessive measures taken 
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by other countries to inform the WHO of those countries suf-
fering from the diseases (9,14). For example, an outbreak of 
cholera in South America (Peru) in 1991 cost about 700 mil-
lion dollars for the country in fields of trade, tourism and the 
like (17,19). Another cause of IHR inefficiency is associated 
with the fact that the WHO is relatively inexperienced in es-
tablishing and applying legal systems (4). The revision and 
modification process is mainly centralized in four key areas:
1. Global Health Security (epidemic alert and response)
2. Public health emergencies at a global level
3. Common preventive measures
4. The need for cooperation between the IHR and other 
relevant international regimes.
GLOBAL HEALTH SECURITY (EPIDEMIC 
ALERT AND RESPONSE)
The WHO activities are to support member states. Imple-
mentation of the WHO strategy for the global health security 
(epidemic alert and response) is to link the IHR and activi-
ties at a global-local level (9). The WHO strategy on glob-
al health security (epidemic alert and response) consists of 
three categories:
1. Programs on the prevention and control of epidem-
ic threats such as cholera and flu. 2. Identification of and 
response to health emergencies caused by unexpected sit-
uations and unknown causes. 3. Statistical consolidation 
through strengthening the national infrastructures to monitor 
and control diseases.
PUBLIC HEALTH EMERGENCIES AT A GLOBAL 
LEVEL
The obligations of the member states to notify the WHO of the 
epidemic diseases must exceed plague, cholera, and yellow 
fever and include all public health emergencies worldwide 
(10). In collaboration with a Swedish Institute, the WHO pro-
posed a specific definition of health-related regulations under 
the revised IHR with regard to infectious diseases. In the re-
vised IHR, there is a national disease surveillance system de-
fined to detect, assess, and respond to health emergencies (7).
COMMON PREVENTIVE MEASURES
Common preventive measures in the IHR have been updated 
according to the dynamic nature of trade and commerce (1).
THE NEED FOR COOPERATION BETWEEN THE 
IHR AND OTHER RELEVANT INTERNATIONAL 
REGIMES
From the prospective of the WHO, complete well-being 
is mental, social, and physical, not merely the absence of 
disease or impairment (1,21). Regarding the relationship 
between trade liberalization and public health, it can be eas-
ily understood what leads to challenges between multilat-
eral trade organizations and the IHR, especially regarding 
the WTO agreements (21). The IHR revision process con-
siders the point that the cooperation between the WTO and 
the health organizations should become more prominent and 
the IHR and the World Trade Organization shall consider 
the world trade minimum interference in the protection of 
public health (9). Since a majority of countries are mem-
bers of WTO and WHO, both organizations are working to 
reduce conflict between these two organizations (14). The 
IHR revision process is to create broad consensus with oth-
er countries and international organizations considering the 
IHR principles and objectives. Some organizations are as 
follows: Food and Agriculture Organization (FAO), the In-
ternational Air Transport Association (IATA), International 
Civil Aviation Organization (ICAO), and International Mari-
time Organization (IMO). The first draft of the IHR was sent 
in early 2003 to help the states and was adopted in 2004 (11).
WORLD TRADE ORGANIZATION AND 
COMMUNICABLE DISEASES
The TRIPs Agreement offers a set of legal frameworks to 
provide the minimum standards for the intellectual property 
protection of achievements like pharmaceutical products (1). 
According to the World Health Organization regulations, ac-
cess to medicine aims to promote access to medicines for all. 
In no field of world public health, no tension was explicitly 
observed between the TRIPs and access to essential medi-
cines and the pressure of the AIDS epidemic in vulnerable 
populations in developing countries, especially in South 
Africa (22). There are, however, pitched battles against the 
intellectual property rights between the global economy and 
pharmaceutical company owners and human rights and civil 
society groups (2,15,16). This complexity can be observed 
in recognizing the litigation by thirty-nine influential multi-
national pharmaceutical companies against the Government 
of South Africa in 1998 and the complaint filed by the USA 
against Brazil at the WTO. In November 2001, a WTO Min-
isterial Conference adopted the Doha Declaration, which 
recognized the gravity of the public health problems afflict-
ing many developing countries, especially HIV/AIDS, tu-
berculosis, malaria, and other epidemics (3,6,11,22). Hence, 
the TRIPs Agreement must be interpreted and implement-
ed in such a way that the WTO members have the right to 
protect the public health and to promote access to medi-
cine (12,17,19). Whether the Doha Declaration will make a 
contribution to ameliorating the communicable disease di-
saster in the developing world is at the very best debatable, 
depending on the presence of key players such as the World 
Trade Organization, the World Health Organization, phar-
maceutical manufacturers, civil society and governments 
to transform the Declaration into practice within their legal 
limits (23). One certain necessity id a sustainable collabora-
tion by the World Health Organization and the World Trade 
Organization in order to balance the public property, public 
health and mutual respect (9).
INTERNATIONAL LAWS AND CONTROL OF 
GLOBAL INFECTIOUS DISEASES
The international law played a significant role in controlling 
infectious diseases during the nineteenth century. Now, the 
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legal frameworks of international organizations like FAO, 
WHO, and WTO can provide for international legal mech-
anisms in forging consensus on a range of issues overtly or 
covertly related to transboundary spread of communicable 
diseases (13). International Health Law, which encompass-
es human rights, food safety, international trade law, envi-
ronmental law, war, weapons and human reproduction, and 
organ transplantation as well as a wide range of biological, 
economic and social factors, now constitute a core compo-
nent of the global communicable disease architecture (11). 
Although most epidemiologists believe that the international 
law has limited resources in the case of global health chal-
lenges, this view is mistaken because the World Health Orga-
nization plays a non-significant role in monitoring infectious 
diseases at a global level and the World Health Organization 
does not possess either the army and the multinational power 
to sanction violators of the WHO health legislations (1).
CONCLUSION
The international law played a critical role in the surveil-
lance and treatment of communicable diseases in interna-
tional health conferences held during the nineteenth centu-
ry. The same role has not continued during the 21st century 
when the globalizations of the world’s political economy 
and of infectious diseases are accelerating inseparably. In-
ternational law has been at the margins of communicable 
disease surveillance, especially within the mandate of WHO 
because the International Health Regulations are not rigor-
ously observed by the member countries. Furthermore, the 
international law is mostly used in monitoring global health. 
Exclusion of diseases from the international law suggests 
that legal interventional means in the global surveillance of 
communicable diseases is infinitely small. In contrast, the 
comprehensive definition of health shows that the global 
health protection and its promotion are not independent from 
human rights, conflict, food insecurity, hunger, poverty, un-
derdevelopment, climate change, and other environmental 
challenges. This indicates that the effect of international law 
in international agreements is undeniable and integral. Ma-
turity and sophistication of international laws are associated 
with discipline and the capacity to regulate each globally 
conceivable topic. Regarding international laws, concerns 
are related to its effectiveness and fairness. Effectiveness of 
international law is primarily assessed based on the reduced 
incidence of diseases and mortality across communities and 
the enforcement of these laws would result in global health 
security.
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